IL2 and cancer: Cytokines, such as GM-CSF, IL-2, IL-12, and IFN-α, play very important roles in cancer treatment, but cytokines generally have short half-lives, act over short distances, and need to be repeatedly administered in short intervals to maintain efficient bioavailability, which limits their widespread clinical use.